Faculty & Staff Directory
L. A. Campbell, PT, DPT, MBA, MSCS
MS Program Coordinator
Dr. Campbell is a physical therapist specializing in the evaluation and treatment of multiple sclerosis (MS) and Devic’s disease. In her time at Barrow, Dr. Campbell has been involved in clinical care, program development, research, and education related to multiple sclerosis. She has extensive experience using multiple methods for the treatment of deficits related to MS, including using the Pilates approach and aquatic therapy with traditional physical therapy interventions.
After graduating with a Bachelor of Arts in Biology (along with a minor in chemistry and an additional focus in literature), Dr. Campbell was awarded the premier award in the Division of Natural Sciences, the Martin Senior Biology Award for Academic Excellence. She holds a Bachelor of Science degree in Physical Therapy from Georgia State University and an MBA from the University of Phoenix. She obtained her Doctor of Physical Therapy degree from A.T. Still University.
Dr. Campbell joined Barrow in 2004 and managed several outpatient clinics and services until December of 2013, when she began focusing on multiple sclerosis clinical programming and development.
Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington's Disease
Date: 01/2020
Authors: Shreaya Chakroborty, Fredric P. Manfredsson, Alexander M. Dec, Peter W. Campbell, Grace E. Stutzmann, Vahri Beaumont, Anthony R. West
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Date: 05/2018
Authors: Raju Kapoor, Pei Ran Ho, Nolan Campbell, Ih Chang, Aaron Deykin, Fiona Forrestal, Nisha Lucas, Bei Yu, Douglas L. Arnold, Mark S. Freedman, Myla D. Goldman, Hans Peter Hartung, Eva Kubala Havrdová, Douglas Jeffery, Aaron Miller, Finn Sellebjerg, Diego Cadavid, Dan Mikol, Deborah Steiner, Emmanuel Bartholomé, Marie D'Hooghe, Massimo Pandolfo, Bart Van Wijmeersch, Virender Bhan, Gregg Blevins, Donald Brunet, Virginia Devonshire, Pierre Duquette, Mark Freedman, François Grand'Maison, François Jacques
Systemic levels of estrogens and PGE2 synthesis in relation to postmenopausal breast cancer risk
Date: 03/2017
Authors: Sangmi Kim, Jeff Campbell, Wonsuk Yoo, Jack A. Taylor, Dale P. Sandler
Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia
Date: 10/2012
Authors: Paul T. Kotzbauer, Nigel J. Cairns, Meghan C. Campbell, Allison W. Willis, Brad A. Racette, Samer D. Tabbal, Joel S. Perlmutter
Radiation arteriopathy in the transgenic arteriovenous fistula model
Date: 05/2008
Authors: Michael T. Lawton, Christine M. Arnold, Yung J. Kim, Ernesto A. Bogarin, Campbell L. Stewart, Amanda A. Wulfstat, Nikita Derugin, Dennis Deen, William L. Young
- English
L. A. Campbell, PT, DPT, MBA, MSCS
MS Program Coordinator
Dr. Campbell is a physical therapist specializing in the evaluation and treatment of multiple sclerosis (MS) and Devic’s disease. In her time at Barrow, Dr. Campbell has been involved in clinical care, program development, research, and education related to multiple sclerosis. She has extensive experience using multiple methods for the treatment of deficits related to MS, including using the Pilates approach and aquatic therapy with traditional physical therapy interventions.
After graduating with a Bachelor of Arts in Biology (along with a minor in chemistry and an additional focus in literature), Dr. Campbell was awarded the premier award in the Division of Natural Sciences, the Martin Senior Biology Award for Academic Excellence. She holds a Bachelor of Science degree in Physical Therapy from Georgia State University and an MBA from the University of Phoenix. She obtained her Doctor of Physical Therapy degree from A.T. Still University.
Dr. Campbell joined Barrow in 2004 and managed several outpatient clinics and services until December of 2013, when she began focusing on multiple sclerosis clinical programming and development.
Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington's Disease
Date: 01/2020
Authors: Shreaya Chakroborty, Fredric P. Manfredsson, Alexander M. Dec, Peter W. Campbell, Grace E. Stutzmann, Vahri Beaumont, Anthony R. West
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Date: 05/2018
Authors: Raju Kapoor, Pei Ran Ho, Nolan Campbell, Ih Chang, Aaron Deykin, Fiona Forrestal, Nisha Lucas, Bei Yu, Douglas L. Arnold, Mark S. Freedman, Myla D. Goldman, Hans Peter Hartung, Eva Kubala Havrdová, Douglas Jeffery, Aaron Miller, Finn Sellebjerg, Diego Cadavid, Dan Mikol, Deborah Steiner, Emmanuel Bartholomé, Marie D'Hooghe, Massimo Pandolfo, Bart Van Wijmeersch, Virender Bhan, Gregg Blevins, Donald Brunet, Virginia Devonshire, Pierre Duquette, Mark Freedman, François Grand'Maison, François Jacques
Systemic levels of estrogens and PGE2 synthesis in relation to postmenopausal breast cancer risk
Date: 03/2017
Authors: Sangmi Kim, Jeff Campbell, Wonsuk Yoo, Jack A. Taylor, Dale P. Sandler
Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia
Date: 10/2012
Authors: Paul T. Kotzbauer, Nigel J. Cairns, Meghan C. Campbell, Allison W. Willis, Brad A. Racette, Samer D. Tabbal, Joel S. Perlmutter
Radiation arteriopathy in the transgenic arteriovenous fistula model
Date: 05/2008
Authors: Michael T. Lawton, Christine M. Arnold, Yung J. Kim, Ernesto A. Bogarin, Campbell L. Stewart, Amanda A. Wulfstat, Nikita Derugin, Dennis Deen, William L. Young
- English